Health Canada warns about contaminated unauthorized injectable peptides and non-peptide drugs
Is your product affected? Check the DIN and lot number on your package against the list in Health Canada's official notice.
See affected DINs and lot numbers on Health Canada ↗Why it was recalled
Unauthorized product - Contamination
What you should do
- If you have used an unauthorized injectable peptide drug and develop symptoms such as redness, swelling, pain at the injection site, fever, chills or you feel unwell, seek medical attention immediately, as these may be signs of a serious infection.
- Do not buy or use unauthorized drugs. Authorized prescription drugs in Canada have an eight-digit Drug Identification Number (DIN) on the label. You can also check whether a drug has been authorized for sale by searching Health Canada's Drug Product Database.
- Do not use drugs that are labelled "For Research Use Only – Not for Human Consumption". These are intended for lab use, not human consumption and can be dangerous to your health.
- Only use prescription drugs prescribed to you under the care of a licensed healthcare professional, and only buy prescription drugs from licensed pharmacies. Be aware of the risks of buying health products online.
- Dispose of unauthorized peptide drugs by following municipal or regional guidance for chemicals and other hazardous waste or take the product to your local pharmacy for proper disposal.
- Report any health product-related side effects or complaints to Health Canada. Your reports help identify potentially dangerous products and protect others from harm.
- Visit Health Canada's Webpage on Peptides to learn more about peptides, their health risks, and steps you can take to protect yourself.
- Related linksHealth Canada peptide safety advisoriesHealth Canada information on peptides
Other Recent Recalls
PDP-DIPHENHYDRAMINE
PDP-DIPHENHYDRAMINE 25 MG and 50 MG CAPSULES: Out-of-specification (Impurity)
Type II2026-11-09
Moderate health risk
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 4g/100mL and Potential Bag Leaks
2026-11-03
Cyclophosphamide for Injection USP
Cyclophosphamide for Injection USP: Presence of particulate matter
Type I2026-10-30
Highest health risk
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.